Willow Biosciences Inc (WLLW) - Cash Flow Conversion Efficiency

Latest as of March 2025: 0.055x

Based on the latest financial reports, Willow Biosciences Inc (WLLW) has a cash flow conversion efficiency ratio of 0.055x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-38.00K ≈ $-27.49K USD) by net assets (CA$-690.00K ≈ $-499.14K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Willow Biosciences Inc - Cash Flow Conversion Efficiency Trend (2000–2024)

This chart illustrates how Willow Biosciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Willow Biosciences Inc (WLLW) financial obligations for a breakdown of total debt and financial obligations.

Willow Biosciences Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Willow Biosciences Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
YGL Convergence Bhd
KLSE:0086
0.001x
Oberstdorfer Bergbahn AG
MU:KVO
N/A
abrdn Asian Income Fund Limited
LSE:AAIF
0.031x
Vintage Energy Ltd
AU:VEN
0.191x
Mask Investments Limited
NSE:MASKINVEST
-0.002x
Mainz Biomed N.V.
NASDAQ:QUCY
N/A
Rayong Wire Industries Public Company Limited
BK:RWI
0.057x
Better Choice Company Inc
NYSE MKT:BTTR
0.048x

Annual Cash Flow Conversion Efficiency for Willow Biosciences Inc (2000–2024)

The table below shows the annual cash flow conversion efficiency of Willow Biosciences Inc from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see Willow Biosciences Inc (WLLW) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CA$-505.00K
≈ $-365.31K
CA$-3.72 Million
≈ $-2.69 Million
7.372x +331.97%
2023-12-31 CA$3.44 Million
≈ $2.49 Million
CA$-10.92 Million
≈ $-7.90 Million
-3.178x -275.40%
2022-12-31 CA$16.37 Million
≈ $11.84 Million
CA$-13.86 Million
≈ $-10.03 Million
-0.847x -37.86%
2021-12-31 CA$29.68 Million
≈ $21.47 Million
CA$-18.23 Million
≈ $-13.19 Million
-0.614x -102.69%
2020-12-31 CA$-559.00K
≈ $-404.37K
CA$-12.78 Million
≈ $-9.24 Million
22.862x +5592.30%
2019-12-31 CA$22.01 Million
≈ $15.92 Million
CA$-9.16 Million
≈ $-6.63 Million
-0.416x +73.93%
2018-12-31 CA$835.03K
≈ $604.05K
CA$-1.33 Million
≈ $-964.33K
-1.596x -143.05%
2017-12-31 CA$-145.01K
≈ $-104.90K
CA$-537.68K
≈ $-388.95K
3.708x +10.99%
2016-12-31 CA$-383.33K
≈ $-277.30K
CA$-1.28 Million
≈ $-926.41K
3.341x +876.08%
2015-12-31 CA$1.01 Million
≈ $728.19K
CA$-433.34K
≈ $-313.47K
-0.430x +3.17%
2014-12-31 CA$1.38 Million
≈ $999.85K
CA$-614.45K
≈ $-444.48K
-0.445x +30.69%
2013-12-31 CA$1.44 Million
≈ $1.04 Million
CA$-921.19K
≈ $-666.37K
-0.641x -502.05%
2012-12-31 CA$901.49K
≈ $652.12K
CA$-96.04K
≈ $-69.48K
-0.107x +52.32%
2011-12-31 CA$2.53 Million
≈ $1.83 Million
CA$-564.70K
≈ $-408.49K
-0.223x +9.07%
2010-12-31 CA$3.52 Million
≈ $2.55 Million
CA$-865.76K
≈ $-626.28K
-0.246x -44.84%
2009-12-31 CA$5.24 Million
≈ $3.79 Million
CA$-889.16K
≈ $-643.20K
-0.170x +36.10%
2008-12-31 CA$3.47 Million
≈ $2.51 Million
CA$-922.61K
≈ $-667.40K
-0.266x +39.98%
2007-12-31 CA$2.50 Million
≈ $1.81 Million
CA$-1.11 Million
≈ $-799.41K
-0.442x -104.59%
2006-12-31 CA$-21.98K
≈ $-15.90K
CA$-211.79K
≈ $-153.21K
9.634x +1974.10%
2005-12-31 CA$-109.44K
≈ $-79.17K
CA$-50.84K
≈ $-36.77K
0.465x +121.24%
2004-12-31 CA$-714.97K
≈ $-517.20K
CA$-150.11K
≈ $-108.59K
0.210x +37667.14%
2002-12-31 CA$-674.55K
≈ $-487.96K
CA$-375.00
≈ $-271.27
0.001x +219.56%
2001-12-31 CA$-604.35K
≈ $-437.18K
CA$281.00
≈ $203.27
0.000x -100.19%
2000-12-31 CA$-441.04K
≈ $-319.04K
CA$-105.17K
≈ $-76.08K
0.238x --

About Willow Biosciences Inc

TO:WLLW Canada Drug Manufacturers - Specialty & Generic
Market Cap
$18.10 Million
CA$25.02 Million CAD
Market Cap Rank
#28310 Global
#1281 in Canada
Share Price
CA$0.17
Change (1 day)
+0.00%
52-Week Range
CA$0.01 - CA$0.32
All Time High
CA$2.08
About

Willow Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has licensing and development partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients and other ingredients. Willow Biosciences Inc. was founded in 20… Read more